If you need more lookups,
subscriptions start at $34 USD/month.
Andreas Segerros Location
Antibes, FR
Andreas Segerros Work
Chief Executive Officer @ (May 2024 - Present)
Chief Executive Officer @ (June 2022 - March 2024)
Founding Partner @ (July 2020 - May 2022)
Chief Executive Officer @ (January 2018 - June 2020)
Partner @ (January 2012 - January 2018)
Venture Partner @ (January 2011 - January 2012)
Vice President Business Development and Operations Planning @ (October 2005 - January 2011)
Chief Executive Officer @ Clinitrac AB (January 2000 - October 2005)
VP Pharmaceutical Ophthalmology @ (January 1998 - December 1999)
VP - Franchise Business @ (January 1995 - January 1998)
Director of Marketing @ (January 1992 - January 1994)
Marketing Manager @ (January 1988 - January 1992)
Director Of Development @ (January 1986 - January 1988)
Andreas Segerros Education
Uppsala University
MBA (International Financing)
1990-1992
KTH Royal Institute of Technology
MSc (Chemistry)
1980-1984
Andreas Segerros Skills
Mergers and Acquisitions
Biotechnology
Strategy
Biopharmaceuticals
Lifesciences
Technology Transfer
Corporate Development
Pharmaceutical Industry
Social Media Marketing
Business Strategy
Mergers
Leadership
Project Management
Start Ups
Oncology
Venture Capital
Commercialization
Medical Devices
Due Diligence
Clinical Development
Strategic Planning
Drug Development
Andreas Segerros Summary
Andreas Segerros, based in Antibes, FR, is currently a Chief Executive Officer at SYLENTIS. Andreas Segerros brings experience from previous roles at Nicox, Eir Ventures, Swedish Biomimetics 3000 Ltd and Sunstone Life Science Ventures. Andreas Segerros holds a 1990 - 1992 MBA in International Financing @ Uppsala University. With a robust skill set that includes Mergers and Acquisitions, Biotechnology, Strategy, Biopharmaceuticals, Lifesciences and more. Andreas Segerros has 3 emails and 2 mobile phone numbers on RocketReach.
Looking for a different Andreas Segerros?
Find contact details for 700 million professionals.